Skip to main content
. 2022 Feb 2;17(2):e0261854. doi: 10.1371/journal.pone.0261854

Table 1. The 20 biosets with the highest correlation to the NF-κB biomarker.

Bioset Name Chemical Cell type Public ID Time of exposure (hrs) Conc (in uM unless otherwise indicated) NF-κB biomarker (-Log(p-value))
Dermal fibroblasts (C18)—3uM sphingosine-1-phosphate treated 4hr _vs_ untreated_GPL6480 Sphingosine 1-phosphate Dermal fibroblasts GSE56308 4 3 15.9
Dermal fibroblasts (NHDF)—3uM sphingosine-1-phosphate treated 4hr _vs_ untreated_GPL6480 Sphingosine 1-phosphate Dermal fibroblasts GSE56308 4 3 15.7
Lung cancer A549 cell line + Nilotinib 30000nM for 4hr _vs_ control Nilotinib A549 E-TABM-585 4 30 15.6
Primary mesothelial HPM3 cells, pleural + 5ug/cm2 crocidolite asbestos for 8hr _vs_ unexposed Asbestos, crocidolite HPM3 GSE63966 8 5ug/cm2 15.2
Paroxetine_20uM_24hr_Chen Paroxetine MCF7 PMID: 24496634 24 20 13.3
Macrophages monocyte-derived 10uM nutlin-3 treated 2hr _vs_ DMSO Nutlin 3 Monocyte-derived macrophages GSE43596 2 10 13.2
Dermal fibroblasts (C18)—3uM sphingosine-1-phosphate treated 8hr _vs_ untreated_GPL6480 Sphingosine 1-phosphate Dermal fibroblasts GSE56308 8 3 13.2
HUVEC cells + 1.5 mM nickel chloride for 5hr _vs_ control Nickel chloride HUVEC GSE4852 5 1500 12.6
Bronchial epithelial BEAS-2B cells treated 4hr with 10ug/ml PM10—indoor _vs_ outdoor Particulate matter BEAS-2B GSE34607 4 10ug/ml 12.2
Huh7 hepatocarcinoma cells 10uM GENK treated for 4hr _vs_ DMSO control Genkwanin HuH-7 GSE39002 4 10 12.2
A549 lung carcinoma cells grown in presence of 10nM geldanamycin (IC20) 48hr _vs_ vehicle Geldanamycin A549 GSE26525 48 0.01 12.2
Monocyte derived dendritic cells + TLR4 agonist R848 2hr _vs_ untreated R848 Monocyte-derived dendridic cells GSE2706 2 2.5 μg/ml 11.8
HEK293 cells overexpression p65-S547A mutant—etoposide treated 8hr _vs_ untreated Etoposide HEK293 GSE33990 8 Not reported 11.5
Bronchial epithelial BEAS-2B cells—4hr 10ug/ml indoor PM10 _vs_ 4hr untreated Particulate matter BEAS-2B GSE34607 4 10ug/ml 11.4
Dermal fibroblasts (NHDF)—3uM sphingosine-1-phosphate treated 8hr _vs_ untreated_GPL6480 Sphingosine 1-phosphate Dermal fibroblasts GSE56308 8 3 11.3
Dermal fibroblasts (NHDF)—3uM sphingosine-1-phosphate treated 12hr _vs_ untreated_GPL6480 Sphingosine 1-phosphate Dermal fibroblasts GSE56308 12 3 11.1
Macrophages treated 6hr with 10ug curdlan _vs_ untreated controls Curdlan Macrophage GSE32282 6 10ug/ml 10.8
Hepatocellular carcinoma hepatocyte HepaRG cells + 6hr 100nM vinblastine _vs_ DMSO Vinblastine HepaRG GSE69851 6 100 10.4
Lung epithelium A549 cells 200ug/ml silica treated from 24hr _vs_ untreated Silicon dioxide A549 GSE30215 24 0.1 10.4
HL60 cells + amphotericin B, 4.4uM _vs_ DMSO vehicle Amphotericin B HL-60 GSE5258 6 4.4 10.3